The
Mount Sinai Hospital is the safest center for patients
undergoing angioplasty in the state, among institutions
performing at least 1,000 procedures from 1995
to 1997, according to a comprehensive report issued
by the New York State Department of Health. Released
on November 19, the report compares risk-adjusted
mortality rates.
Largely
responsible for this result, Samin Sharma, MD, Director
of Interventional Cardiology at Mount Sinai, achieved
the highest level of success for angioplasty safety
in the state among all physicians. Dr. Sharma has served
as Director of the Mount Sinai Catheterization Laboratory
since 1996. He is widely recognized for his expertise
in angioplasty, having performed 1,447 interventions
from 1995 to 1997 and more than 1,000 a year since,
with an extremely low complication rate (less than
two-tenths of one percent). He is also known for taking
the most difficult cases referred from other hospitals.
"As a team, we
really have developed
a system of opening
the blockage in the
safest way," Dr.
Sharma explains. "To
achieve optimal success
in angioplasty, it
is absolutely essential
to understand the health
of the patient as a
whole, rather than
focus solely on the
procedure. When I'm
doing a procedure,
I am not just looking
at the region of blockage.
I am also seeing how
the patient is doing,
how the blood pressure
is, how the chest pain
is. I'm looking at
everything."
"In addition
to procedural techniques,
this [whole-patient
approach] is what I
teach, " says
Dr. Sharma, who received
the Teacher of the
Year Award in 2000. "I
also emphasize to my
students that trust
must be built between
the doctor and the
patient, ensuring the
patient's complete
confidence."
Angioplasty, a non-surgical
procedure, is used
to open arteries clogged
by the accumulation
of cholesterol and
other fatty molecules,
known as plaque, inside
an artery. Plaque can
slow or stop the flow
of blood to the heart,
and cleaning arteries
by means of angiolplasty,
to restore normal blood
flow, is often the
treatment of choice.
Balloon angioplasty
(technically called
percutaneous transluminal
coronary angioplasty,
or PTCA) is the most
common form of angioplasty.
In this procedure,
the interventional
cardiologist inserts
a hollow, narrow tube,
called a catheter,
into the groin of the
patient. Monitoring
the path of the catheter
with X-ray technology,
the cardiologist then
painstakingly threads
the catheter up to
the arterial blockage.
A second, thinner catheter
is then inserted into
the first hollow tube.
Once in position,
a miniature balloon
at the tip of the inner
catheter is inflated,
pushing out against
the artery-clogging
plaque and making the
opening slightly wider.
Frequently a thin wire
mesh tube, called a
stent, is inserted
by a third catheter.
The stent functions
as scaffolding, helping
to prevent the artery
from reclogging.
"Success is due
to careful preparation
of the patient and
the skilled use of
various devices, including
the rotoblator, " says
Dr. Sharma, who is
considered by cardiologists
to be a master in the
skilled use of this
difficult instrument.
Attached at the tip
of another catheter,
the rotoblator is a
miniature, diamond-tipped
power drill that can
operate at a speed
60 times that of a
car engine. When used
during angioplasty,
it is inserted through
the first catheter
before the insertion
of the balloon catheter
to pulverize plaque
when the blockage is
especially dense.
|